Kathryn L. Weise

Kathryn L. Weise

Auto-generated profile, based on publicly available information

Kathryn L. Weise

Department of Bioethics, Cleveland Clinic, and Pediatric Institute, Cleveland Clinic Children's, Cleveland, Ohio

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Pediatrics
Verified
Journal Article
Open access
PDF file
KWKathryn L. Weise
Kathryn L. Weise
AOAlexander L. Okun
Alexander L. Okun
BCBrian S. Carter
Brian S. Carter
CCCindy W. Christian
Cindy W. Christian
CBCOMMITTEE ON BIOETHICS
COMMITTEE ON BIOETHICS
SHSection On Hospice
Section On Hospice
This Policy Statement was reaffirmed June 13, 2023.: Pediatric health care is practiced with the goal of promoting the best interests of the child. Treatment generally is rendered under a presumption in favor of sustaining life. However, in some circumstances, the balance of benefits and burdens to the child leads to an assessment that forgoing life-sustaining medical treatment (LSMT) is ethically supportable or advisable. Parents are given wide latitude in decision-making concerning end-of-life care for their children in most situations. Collaborative decision-making around LSMT is improved by thorough communication among all stakeholders, including medical staff, the family, and the patient, when possible, throughout the evolving course of the patient’s illness. Clear communication of overall goals of care is advised to promote agreed-on plans, including resuscitation status. Perceived disagreement among the team of professionals may be stressful to families. At the same time, understanding the range of professional opinions behind treatment recommendations is critical to informing family decision-making. Input from specialists in palliative care, ethics, pastoral care, and other disciplines enhances support for families and medical staff when decisions to forgo LSMT are being considered. Understanding specific applicability of institutional, regional, state, and national regulations related to forgoing LSMT is important to practice ethically within existing legal frameworks. This guidance represents an update of the 1994 statement from the American Academy of Pediatrics on forgoing LSMT.

1 September 2002 in Pediatrics
Verified
Journal Article
Closed access
KWKathryn L. Weise
Kathryn L. Weise
MSMartin L. Smith
Martin L. Smith
KMKaren J. Maschke
Karen J. Maschke
HCH. Liesel Copeland
H. Liesel Copeland
Objective. Payment to subjects for participation in research is reportedly common, but no published data documents the nature of this practice. Institutional review boards (IRBs) are responsible for ensuring both the safety and voluntary participation of research subjects, yet guidance from federal and expert pediatric sources regarding appropriate payment approaches is conflicting. Ethical issues of payment for participation of adult versus pediatric research subjects may differ. This empirical study sought to examine current payment practices for participation in pediatric research as reported by IRBs. Design. An 18-question survey regarding payment practices for participation in pediatric research was sent to IRB chairs at member institutions of the National Association of Children’s Hospitals and Related Institutions, and to a systematic random sample of IRB chairs listed with the Office for Protection From Research Risks. Descriptive, nonparametric, and qualitative analyses were used to describe institution types, payment practices, and correlations among responses. Results. Data from 128 institutions that conduct pediatric research revealed that payment for participation in pediatric research was allowed by 66% of responding institutions, and practices varied widely among institutions. Most responding IRBs that allowed payment required disclosure of payment before enrollment (during the consent process), following federal guidelines more closely than American Academy of Pediatrics guidelines. An IRB’s perception of potential benefits or harms of a study correlated with the amount of payment approved. Conclusions. IRBs must balance the need to recruit pediatric research subjects against the risk of undue influence during the recruitment process. Federal guidelines and expert pediatric opinion differ in recommendations regarding payment; responding IRBs appeared to follow federal guidelines more closely than guidelines proposed by the American Academy of Pediatrics.

8 May 2014 in The American Journal of Bioethics
Verified
Journal Article
Closed access
KWKathryn L. Weise
Kathryn L. Weise
BDBarbara J. Daly
Barbara J. Daly
Clinical ethics consultants represent a multidisciplinary group of scholars and practitioners with varied training backgrounds, who are integrated into a medical environment to assist in the provision of ethically supportable care. Little has been written about the degree to which such consultants are accountable for the patient care outcome of the advice given. We propose a model for examining degrees of internally motivated accountability that range from restricted to unbounded accountability, and support balanced accountability as a goal for practice. Finally, we explore implications of this model for training of clinical ethics consultants from diverse academic backgrounds, including those disciplines that do not have a formal code of ethics relating to clinical practice.

4 May 2015 in The American Journal of Bioethics
Verified
Journal Article
Closed access
KWKathryn L. Weise
Kathryn L. Weise
CGColleen M. Gallagher
Colleen M. Gallagher
JHJames Andrew Hynds
James Andrew Hynds
BSBarbara Lynn Secker
Barbara Lynn Secker
BWBruce David White
Bruce David White